← FDA Drug Approvals (Drugs@FDA)
DIPENTUM
NDA · New Drug Application · Sponsor: MYLAN SPCLT VIATRIS · Approved 1990-07-31
Drug application
- FDA Application #
NDA019715- Application type
- New Drug Application
- Brand name
- DIPENTUM
- Generic name
- OLSALAZINE SODIUM
- Active ingredients
- OLSALAZINE SODIUM
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MYLAN SPCLT VIATRIS
- Manufacturer
- Viatris Specialty LLC
- First approval
- 1990-07-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown